STADA Poland

STADA Poland is the Polish subsidiary of the global pharmaceutical group STADA Arzneimittel AG, specializing in three core pillars: Consumer Healthcare, Generics, and Specialty Medicines. The company maintains a strong market presence in Poland through a diverse portfolio of over-the-counter (OTC) brands such as Nizoral, Cholinex, and Orofar, as well as the Walmark line of dietary supplements. In the specialty segment, STADA Poland focuses on high-growth areas including biosimilars and neurology, notably providing advanced infusion therapies for Parkinson's disease. The company leverages its parent's global manufacturing and R&D capabilities to deliver affordable, high-quality healthcare solutions to the Polish market.